← Human Trials & Peer-Reviewed Studies
The effect of pregnancy vitamin D supplementation on maternal blood pressure: real-world data analysis within the MAVIDOS randomised placebo-controlled trial.
Plain-language guide to PMID 39880969 (2025): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc, low blood pressure and orthostatic hypotension.
Key Facts
- PMID
- 39880969
- Journal
- Archives of gynecology and obstetrics
- Year
- 2025
- Study type
- Randomized Controlled Trial
- Authors
- Citeroni-Clark NL et al. (8 authors)
- DOI
- 10.1007/s00404-025-07958-z
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc in the context of low blood pressure and orthostatic hypotension, published as a randomized controlled trial.
Data from intervention studies are limited.
Who Took Part
PubMed indexes the participants as adults, women only.
BP recordings documented during routine clinical pregnancy care were obtained from clinical records and grouped into gestational windows based on the schedule for routine antenatal care in the United Kingdom (23+0-24+6, 27+0-28+6, 33+0-35+6, 37+0-38+6, 39+0-40+6 and ≥ 41+0 weeks+days).
Systolic and diastolic BP measurements in these gestational windows were compared between randomisation groups.
How the Study Was Run
The design is described as randomized and placebo-controlled.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Some participants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
The Maternal Vitamin D Osteoporosis Study (MAVIDOS) was a randomised placebo-controlled trial.
Diagnoses of PIH or PET (in accordance with national guidelines) and the use of antihypertensive agents were also noted and compared between groups.
What Was Measured
Topics PubMed links to this paper include Vitamin D, Blood Pressure, Dietary Supplements, Hypertension, Pregnancy-Induced, Pre-Eclampsia, Cholecalciferol and Vitamins.
Author keywords: Hypertensive disorders of pregnancy, Preeclampsia and Pregnancy-induced hypertension.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in people with low blood pressure and orthostatic hypotension.
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2025 (Archives of gynecology and obstetrics), a journal based in Germany.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, Low blood pressure and orthostatic hypotension research.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
- Low blood pressure and orthostatic hypotension research
- Vitamin D, K2, Magnesium and Zinc in the library
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.